SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-003081
Filing Date
2024-01-08
Accepted
2024-01-08 18:03:03
Documents
1
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7388
  Complete submission text file 0000950170-24-003081.txt   9097
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMARIN PHARMA, INC. 1430 ROUTE 206 BEDMINSTER NJ 07921
Business Address
Berg Aaron (Reporting) CIK: 0001770259 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 24521291